articles Coronary heart disease (CHD) is a major cause of morbidity and mortality in the developed world. 1 Oxidative modification of low-density lipoproteins (LDLs) in the arterial wall could play a key role in the pathogenesis of atherosclerosis. 2 Oxidized LDL (oxLDL) in plasma and in atherosclerotic lesions has been strongly associated with the incidence of coronary events and vulnerable plaques. 3,4 Elevated concentrations of circulating oxLDL are predictors for cardiovascular disease both in CHD patients 5 and in the general population. 6 Hypertension is one of the main cardiovascular disease risk factors, 7 particularly in elderly populations. 8 A direct linear relationship between blood pressure levels and the incidence of atherosclerotic vascular disease has been reported. 9 Oxidative stress and LDL oxidation has been related to hypertension via endothelial dysfunction 10-12 which contributes to make the atherosclerotic plaque more unstable, 13 thus increasing the likelihood of coronary events, particularly in patients at high cardiovascular risk. Several human studies support a role of oxidative stress in the development of hypertension. 10 The activities of the antioxidant scavenger enzymes superoxide dismutase and glutathione peroxidase were reduced in untreated hypertensive patients, superoxide dismutase activity being inversely related to blood pressure levels in the hypertensive group, but not in the normotensive one. 14 An increased oxidative stress has been observed in hypertensive patients with renovascular disease, the urinary isoprostane levels, as marker of lipid peroxidation, being reduced after angioplasty. 15 Both systolic (SBP) and diastolic (DBP) blood pressures have been shown to directly correlate with plasma and urinary isoprostanes and negatively with plasma vitamin C and the reduced/ oxidized glutathione ratio. 
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Background
In elderly individuals, hypertension is a main risk factor for cardiovascular disease and oxidative damage is increased. Our aim was to assess the relationship between the degree of in vivo lowdensity lipoprotein (oxLDL) oxidation and the hypertensive status in a elderly population at high cardiovascular risk.
Methods
Cross-sectional study with baseline data from the PrEDIMED (PrEvención con DIeta MEDiterránea) trial, an intervention study directed at testing the efficacy of the Mediterranean diet on the primary prevention of cardiovascular disease. Participants were 1,130 subjects at high cardiovascular risk aged 55-80. at baseline, in vivo circulating oxLDL was measured, and stages of hypertension determined according to the uSa joint national Committee guidelines. results a positive relationship between in vivo oxLDL and systolic and diastolic blood pressure (DBP) was observed after adjusting for confounding factors (P < 0.05). OxLDL concentrations increased in a linear manner from low to high hypertensive stages (P < 0.05).
conclusions Elderly individuals at high cardiovascular risk showed higher levels of circulating oxLDL when their hypertensive status increased. This fact identifies the hypertensive elderly population as a target for antioxidant preventive measures. 
Hypertension and Lipoprotein Oxidation
Previous studies using indirect measurements of LDL oxidation, such as the susceptibility of the LDL to in vitro oxidation and the generation of antibodies against oxLDL, suggested a higher degree of LDL oxidation in hypertensive individuals than in normotensive ones. 17, 18 In a case-control study, hypertensive patients showed higher in vivo circulating oxLDL levels than normotensive subjects. 19 Recent results from a crosssectional study reported a positive relationship between in vivo oxLDL and a prehypertensive status in a general population. 20 The contribution of the degree of in vivo LDL oxidation to the hypertensive status in populations at high cardiovascular risk has not been previously described. The aim of the present study was to assess the relationship between oxLDL, blood pressure levels, and hypertensive status in elderly individuals at high risk for cardiovascular disease.
Methods
Study design. A cross-sectional study with baseline data from the PREDIMED (Efecto de la Dieta Mediterránea en la Prevención Primaria de la Enfermedad Cardiovascular) study was performed. The PREDIMED study is a large, parallelgroup, multicenter, randomized, controlled, 4-year clinical trial aimed at assessing the effects of the Traditional Mediterranean Diet (TMD) on the primary prevention of cardiovascular disease (http://www.predimed.org). The detailed protocol of the study has been previously published. 21 The Institutional Review Boards of the institutions involved approved the study protocol and participants signed an informed consent.
Subjects. From October 2003 to January 2005, a total of 1,130 asymptomatic subjects at high risk for CHD, aged 55-80 years, were selected in 10 Spanish Primary Care Centres. Inclusion criteria were to have three or more CHD risk factors (current smoking, systolic blood pressure (SBP) >140, DBP >90 mm Hg, treatment with antihypertensive drugs, high-density lipoprotein (HDL) cholesterol <40 mg/dl, LDL-cholesterol >160 mg/dl, treatment with hypolipidemic drugs, body mass index >25 kg/m 2 , family history of premature CHD) or diabetes. Exclusion criteria were history of cardiovascular disease, any severe chronic illness, drug or alcohol addiction, history of allergy or intolerance to olive oil or nuts, or low predicted likelihood of changing dietary habits according to the stages of change model. Participants' eligibility was based on a screening visit by the physician.
Baseline assessments. The baseline examination included the administration of: (i) a validated food frequency questionnaire, 22 and its shortened version: a 14-item questionnaire to assess the degree of adherence to the TMD 23 (values of 0 or 1 were assigned to each of the 14 items). Energy and nutrient intake were calculated from Spanish food composition tables; 24 (ii) the Minnesota Leisure Time Physical Activity, validated for its use in Spanish men and women; 25, 26 and (iii) a 47-item general questionnaire assessing life-style, health conditions, smoking habits, sociodemographic variables, history of illness, and medication use. We undertook all clinical procedures in accordance with the PREDIMED study manual of operations. Weight and height were measured with calibrated scales and a wall-mounted stadiometer, respectively. Body mass index was calculated as weight in kilograms divided by the square of height in meters. Waist circumference was measured midway between the lowest rib and the iliac crest using an anthropometric tape. Trained personnel measured blood pressure in triplicate with a validated semiautomatic sphygmomanometer (Omron HEM-705CP, Hoofddorp, The Netherlands) in a seated position after a 5-min rest.
The staging of blood pressure severity was determined according to the US Joint National Committee 28 According to the US Joint National Committee Guidelines 2003 criteria for hypertension stages, only 3.8% (n = 43) of our population were normal and 23.7% (n = 268) were prehypertensive. Because of this, we joined them in a normal/prehypertension category, in which 40% (n = 124) were nontreated individuals.
Laboratory analysis. Biological samples were obtained after an overnight fast, coded, shipped to central laboratories, and frozen at −80 º C until the assay. Glucose and lipid analyses were performed in a PENTRA-400 autoanalyzer (ABX-Horiba Diagnostics, Montpellier, France). Serum glucose, total cholesterol, and triglyceride levels were measured using standard enzymatic automated methods (ABX-Horiba Diagnostics, Montpellier, France). HDL-cholesterol was directly determined by an accelerator selective detergent method (ABXHoriba Diagnostics, Montpellier, France). LDL-cholesterol was calculated by the Friedewald equation whenever triglycerides were <3.4 mmol/l. Quality control was performed with the External Quality Assessment UNITY (Bio-Rad, Hercules, CA). Circulating oxLDL plasma levels were measured by an enzyme-linked immunosorbent assay using the mAb-4E6 antibody as capture antibody, and a peroxidase-conjugated antibody against oxidized apolipoprotein B bound to the solid phase (Mercodia AB, Uppsala, Sweden). Intra-and interassay CVs were 2.8 and 7.3%, respectively.
Sample size and power analysis. Our sample size is >80% powered to detect as statistically significant differences of 10 U/l between at least two of the four groups of hypertensive status, assuming a standard deviation of 20 U/l, a type I error of 0.05 in a two-sided test.
Statistical analyses. Normality of continuous variables was assessed by normal probability plots. OxLDL was normally distributed. Differences in continuous variables between the hypertensive stages were analyzed by one-factor analysis of variance or nonparametric Kruskal-Wallis test as appropriate, and by the χ 2 test for categorical variables. Univariate analyses articles Hypertension and Lipoprotein Oxidation were used to assess the crude relationship among oxLDL tertiles and SBP or DBP. The relationship between oxLDL and SPB, DBP, or hypertensive stages was assessed by linear regression models adjusted for potential confounders. Three models were fitted with each independent variable. Age and sex were adjusted for in the first model (model 1). A second model (model 2) was fitted adjusting for sex, age, glucose, LDL/HDL ratio, and sodium intake (variables in which differences of P < 0.10 across oxLDL, SPB, and DBP levels, and hypertensive stages were observed). An additional model (model 3) was fitted including variables of model 2 plus other variables related with hypertension and oxLDL levels such as smoking, treatment with lipid-lowering agents or angiotensin-converting enzyme inhibitors, and potassium intake. All first-order interactions were also tested. Diagnostics for detection of outliers, multicolinearity, homoscedasticity, and normality Table 1 shows the characteristics of the participants by hypertensive stages. Of the 1,130 participants, 55% were female. Participants' mean age was 67 ± 8 years. The age, SBP, DBP, body mass index, and the proportion of the participants taking angiotensin-converting enzyme inhibitors increased significantly across hypertensive stages, as well as levels of glucose and oxLDL (P < 0.05) whereas sodium intake decreased (P < 0.01). The inverse linear relationship between hypertensive stages and the baseline adherence to the TMD was borderline significant (P = 0.062). A similar trend was observed across SBP and DBP tertiles (P < 0.05) (data not shown). Both blood pressures, SBP and DBP, increased across oxLDL tertiles, showing a significant linear trend (P < 0.01) (Figure 1) .
In multivariate analyses, SBP (adjusted R 2 = 0.17, P < 0.05) and DBP (adjusted R 2 = 0.17, P < 0.01) were positively associated with oxLDL after taking into account the potential confounding effect of sex, age, glucose, LDL/HDL ratio, tobacco consumption, lipid-lowering agents, angiotensin-converting enzyme inhibitors, and sodium and potassium intake ( Table 2) . The positive association of oxLDL with hypertension stages was analyzed after adjustment for the above mentioned confounders ( Table 3) . OxLDL increased in a linear manner across the hypertensive stages (P for linear trend <0.05), levels at stage 2b of hypertension showing a significant difference compared Adjusted for variables of model 2 plus tobacco consumption, lipid-lowering agents, angiotensin-converting enzyme inhibitors, and potassium intake. HTA, hypertension. * P value for differences; ** P value for linear trend across hypertensive stages. N = 1,130 ). *P value <0.01, **P value <0.01, and # P value <0.01 vs. low tertile.
articles Hypertension and Lipoprotein Oxidation with the normal/prehypertension group (adjusted R 2 = 0.17, P < 0.05) ( Table 3) . In these models, circulating oxLDL was directly associated with the LDL/HDL ratio (P < 0.001). When the model was fitted with plasma LDL-cholesterol or HDLcholesterol, instead of the LDL/HDL ratio, they were directly or inversely, respectively, related to oxLDL (P < 0.001). Other variables, including medications, in the model did not show significance. Similar results were obtained when the normal/ prehypertension group was divided in treated and nontreated individuals.
None of the first-order interactions between SBP, SDP, or hypertensive stages and age, sex, diabetes, smoking, body mass index, daily energy expenditure in leisure-time physical activity, treatment with lipid-lowering agents, and angiotensinconverting enzyme inhibitors on levels of oxLDL was statistically significant.
discussion
In this study, an increasing gradient of in vivo oxLDL plasma concentrations was observed from a low to a high hypertensive stage in an elderly population at high cardiovascular risk. oxLDL was also positively and independently correlated with both SBP and DBP levels.
High LDL levels provide a higher substrate for the free radical attack of the lipoprotein. 29 oxLDLs have been shown to correlate directly with LDL-cholesterol and inversely with HDL-cholesterol in this and other studies. 29, 30 Given that our results were adjusted by these lipoproteins, we can assume an independent relationship between hypertensive stages and circulating oxLDL. Previous studies using indirect measurements of LDL oxidation, such as the susceptibility of the LDL to in vitro oxidation and the generation of antibodies against oxLDL, suggested a higher degree of LDL oxidation in hypertensive individuals than in normotensive ones. 17, 18 Our results agree with those obtained in a case-control study, in which hypertensive patients showed higher in vivo circulating oxLDL levels than normotensive subjects. 19 Also, recent results from a cross-sectional study reported a positive relationship between in vivo oxLDL and a prehypertensive status in a general population. 20 Here we report a relationship between the stage of established hypertension, according with guideline criteria, 27 and the in vivo LDL oxidation in an elderly population at a high risk for CHD. Our data support the idea of the inclusion of antioxidant therapies in the management of hypertension in elderly subjects. Adoption of healthy lifestyles, such as antioxidant-rich diets, is critical for the prevention and treatment of arterial hypertension. 31 Recent results of the PREDIMED study showed a decrease in both the blood pressure 21 and the oxLDL plasma concentrations 32 of the participants after 3 months of allocation to TMD with high contents of antioxidants and polyphenols. An inverse association between the adherence to the TMD and blood pressure has also been reported in a cross-sectional study within the Greek EPIC Cohort. 33 In addition, an inverse association between olive oil and the incidence of hypertension in men has also been reported in a Spanish cohort study. 34 Plasma total antioxidant capacity was inversely related with the SBP in the ATTICA study. 20 In agreement with the data referred to above, in our study the adherence to the TMD was lower when the degree of hypertension of the participants increased. The reported salt ingestion was also lower in hypertensive stages, as could be expected from the physicians' indications given to hypertensive patients. Both healthy dietary patterns and low-salt intake are today considered as complementary strategies for the prevention and management of hypertension. 35 The Mediterranean dietary pattern is similar to that of the Dietary Approaches to Stop Hypertension diet, which was shown to substantially lower the blood pressure despite the fact of not being particularly low in sodium. 36 The Dietary Approaches to Stop Hypertension diet reduced SBP by 5.5 mm Hg and DBP by 3.3 mm Hg in front of a control diet. 37 Similar reductions were obtained in a subsample of the PREDIMED Study after a 3-month intervention with a TMD. 21 Differences in daily sodium intake among normal/prehypertensive to hypertensive 2b stage in our population were of 368 mg. In the Dietary Approaches to Stop HypertensionSodium trial, a reduction of 1,150 mg/day of sodium intake, from high to intermediate and from intermediate to low, reduced SBP by 2.1 and 4.6 mm Hg, respectively, in the control group and 1.3 and 1.7 mm Hg in the Dietary Approaches to Stop Hypertension diet group. 38 However, from our knowledge, the comparative effectiveness of both strategies, reducing salt intake vs. a healthy dietary pattern, has not been tested. Our results reinforce the role of healthy dietary patterns in the management and prevention of hypertension.
According to our data, a change from normal/prehypertension to hypertension stage 1 and stage 2b was related with an increase of 3 and 6 U/l of oxLDL, respectively. The current state-of-the art does not, unfortunately, allow an estimation of the attributable cardiovascular risk associated with a 1 U/l change of oxLDL. In a recent study, 6 however, the mean difference in circulating oxLDL values between CHD patients and healthy controls, measured by using the same antibody and method as in the present study, was 17 U/L. From our data and those of others, it can be hypothesized that a reduction in the degree of LDL oxidation may contribute, at least in part, to a decrease of the cardiovascular risk associated with hypertensive states. Further prospective studies are needed, and the follow-up of the whole PREDIMED trial will eventually provide the information.
This study has strengths and limitations. One strength is that it is based on a large sample size and carefully conducted with standardized protocols. Also, participants fulfilled a validated food frequency questionnaire which allowed us to take into account the intake of sodium and potassium, electrolytes with a strong relationship with hypertension. 39 A limitation of our study is its cross-sectional nature which does not permit the establishment causal relationships. Also, our results focused on an elderly population and could not to be extrapolable to a general population.
In summary, elderly individuals at a high risk for CHD showed an increase in circulating in vivo oxLDL plasma articles Hypertension and Lipoprotein Oxidation concentrations when their hypertensive status increased. This fact identifies the elderly hypertensive population as a target for antioxidant preventive measures in order to lower their cardiovascular risk.
